Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.
Zacks Small Cap Research on MSN13h
RANI: Impressive Bioavailability for RT-116RANI READ THE FULL RANI RESEARCH REPORT On February 5th, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...
Weight loss drugs continue to make headlines. A new study conducted by researchers from the University of Southern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback